PGD2 receptor antagonists for the treatment of inflammatory diseases
申请人:Ghosh Shomir
公开号:US20050256158A1
公开(公告)日:2005-11-17
Disclosed herein are compounds represented by Structural Formula (I) and (I-A):
Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.